• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级淋巴结构(TLSs)和基质血管对乳腺癌分子亚型的复发、血管淋巴管和神经周围侵犯具有显著且不同的影响。

Tertiary Lymphoid Structures (TLSs) and Stromal Blood Vessels Have Significant and Heterogeneous Impact on Recurrence, Lymphovascular and Perineural Invasion amongst Breast Cancer Molecular Subtypes.

机构信息

Department of Microscopic Morphology/Histology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.

Doctoral School in Medicine, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.

出版信息

Cells. 2023 Apr 17;12(8):1176. doi: 10.3390/cells12081176.

DOI:10.3390/cells12081176
PMID:37190085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10136904/
Abstract

BACKGROUND

Tertiary lymphoid structures (TLSs) mediate local antitumor immunity, and interest in them significantly increased since cancer immunotherapy was implemented. We examined TLS- tumor stromal blood vessel interplay for each breast cancer (BC) molecular subtype related to recurrence, lymphovascular invasion (LVI), and perineural invasion (PnI).

METHODS

TLSs were quantified on hematoxylin and eosin stain specimens followed by CD34/smooth muscle actin (SMA) double immunostaining for stromal blood vessel maturation assessment. Statistical analysis linked microscopy to recurrence, LVI, and PnI.

RESULTS

TLS negative (TLS-) subgroups in each BC molecular subtype (except to Luminal A) have higher LVI, PnI, and recurrence. A significant rise in LVI and PnI were observed for the HER2+/TLS- subgroup ( < 0.001). The triple negative breast cancer (TNBC)/TLS- subgroup had the highest recurrence and invasion risk which was also significantly related to tumor grade. PnI but not LVI significantly influenced recurrence in the TNBC/TLS+ subgroup ( < 0.001). TLS-stromal blood vessel interrelation was different amongst BC molecular subtypes.

CONCLUSION

BC invasion and recurrence are strongly influenced by TLS presence and stromal blood vessels, especially for HER2 and TNBC BC molecular subtypes.

摘要

背景

三级淋巴结构 (TLS) 介导局部抗肿瘤免疫,自癌症免疫疗法实施以来,人们对其的兴趣显著增加。我们研究了与复发、淋巴血管侵犯 (LVI) 和神经周围侵犯 (PnI) 相关的每种乳腺癌 (BC) 分子亚型的 TLS-肿瘤基质血管相互作用。

方法

通过 CD34/平滑肌肌动蛋白 (SMA) 双重免疫染色评估基质血管成熟度,对苏木精和伊红染色标本进行 TLS 定量。将显微镜与复发、LVI 和 PnI 相关联进行统计分析。

结果

每种 BC 分子亚型的 TLS-(TLS-)亚组(除 Luminal A 外)的 LVI、PnI 和复发率更高。HER2+/TLS-亚组的 LVI 和 PnI 显著增加(<0.001)。三阴性乳腺癌 (TNBC)/TLS-亚组的复发和侵袭风险最高,与肿瘤分级也有显著关系。与 TNBC/TLS+亚组相比,仅 PnI 而不是 LVI 显著影响复发(<0.001)。BC 分子亚型之间的 TLS-基质血管相互关系不同。

结论

TLS 的存在和基质血管强烈影响 BC 的侵袭和复发,尤其是对于 HER2 和 TNBC BC 分子亚型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7c/10136904/e6a2c2ce54c6/cells-12-01176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7c/10136904/cf24f90efbc1/cells-12-01176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7c/10136904/e6a2c2ce54c6/cells-12-01176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7c/10136904/cf24f90efbc1/cells-12-01176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9f7c/10136904/e6a2c2ce54c6/cells-12-01176-g002.jpg

相似文献

1
Tertiary Lymphoid Structures (TLSs) and Stromal Blood Vessels Have Significant and Heterogeneous Impact on Recurrence, Lymphovascular and Perineural Invasion amongst Breast Cancer Molecular Subtypes.三级淋巴结构(TLSs)和基质血管对乳腺癌分子亚型的复发、血管淋巴管和神经周围侵犯具有显著且不同的影响。
Cells. 2023 Apr 17;12(8):1176. doi: 10.3390/cells12081176.
2
Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.HER2 阳性和阴性乳腺癌中独特的三级淋巴结构关联及其预后相关性。
Oncologist. 2017 Nov;22(11):1316-1324. doi: 10.1634/theoncologist.2017-0029. Epub 2017 Jul 12.
3
Triple-negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding.基于三级淋巴结构和肿瘤芽生的人工智能综合分析预测三阴性乳腺癌的生存情况
Cancer. 2024 Apr 15;130(S8):1499-1512. doi: 10.1002/cncr.35261. Epub 2024 Feb 29.
4
Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters.宫颈癌相关三级淋巴结构(TLSs)的异质性及其与临床病理参数的特定相互关系。
Cureus. 2024 Apr 26;16(4):e59077. doi: 10.7759/cureus.59077. eCollection 2024 Apr.
5
Reassessing Breast Cancer-Associated Fibroblasts (CAFs) Interactions with Other Stromal Components and Clinico-Pathologic Parameters by Using Immunohistochemistry and Digital Image Analysis (DIA).通过免疫组织化学和数字图像分析(DIA)重新评估乳腺癌相关成纤维细胞(CAFs)与其他基质成分及临床病理参数的相互作用。
Cancers (Basel). 2023 Jul 27;15(15):3823. doi: 10.3390/cancers15153823.
6
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.食管鳞状细胞癌中三级淋巴结构的预后价值和分子特性。
Clin Transl Med. 2022 Oct;12(10):e1074. doi: 10.1002/ctm2.1074.
7
The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.三阴性淋巴结构的存在为乳腺癌患者的临床病理特征和预后提供了新的见解。
Front Immunol. 2022 May 19;13:868155. doi: 10.3389/fimmu.2022.868155. eCollection 2022.
8
Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.三级淋巴结构和相关浆细胞在三阴性乳腺癌的生物学中发挥重要作用。
Breast Cancer Res Treat. 2020 Apr;180(2):369-377. doi: 10.1007/s10549-020-05548-y. Epub 2020 Feb 7.
9
Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.在三阴性乳腺癌新辅助治疗背景下,通过高内皮静脉计数评估三级淋巴结构的预测价值。
Cancer Res Treat. 2017 Apr;49(2):399-407. doi: 10.4143/crt.2016.215. Epub 2016 Jul 27.
10
Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.滤泡样三级淋巴结构:喉鳞状细胞癌患者预后和免疫治疗反应的潜在生物标志物。
Front Immunol. 2023 Jan 27;14:1096220. doi: 10.3389/fimmu.2023.1096220. eCollection 2023.

引用本文的文献

1
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures.对具有三级淋巴结构的三阴性乳腺癌中免疫检查点阻断反应的空间转录组分析。
iScience. 2025 Jun 2;28(7):112808. doi: 10.1016/j.isci.2025.112808. eCollection 2025 Jul 18.
2
Perineural Invasion in Breast Cancer: A Comprehensive Review.乳腺癌中的神经周围浸润:综述
Cancers (Basel). 2025 Jun 6;17(12):1900. doi: 10.3390/cancers17121900.
3
Development of a tertiary lymphoid structure-based prognostic model for breast cancer: integrating single-cell sequencing and machine learning to enhance patient outcomes.

本文引用的文献

1
Emphasis on Adipocyte Transformation: Anti-Inflammatory Agents to Prevent the Development of Cancer-Associated Adipocytes.对脂肪细胞转化的重视:预防癌症相关脂肪细胞形成的抗炎药物。
Cancers (Basel). 2023 Jan 13;15(2):502. doi: 10.3390/cancers15020502.
2
Tertiary lymphoid structures in breast ductal carcinoma in situ correlate with adverse pathological parameters.乳腺导管原位癌中的三级淋巴结构与不良病理参数相关。
Histopathology. 2023 Apr;82(5):779-788. doi: 10.1111/his.14865. Epub 2023 Jan 30.
3
Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer.
基于三级淋巴结构的乳腺癌预后模型的开发:整合单细胞测序和机器学习以改善患者预后。
Front Immunol. 2025 Feb 26;16:1534928. doi: 10.3389/fimmu.2025.1534928. eCollection 2025.
4
Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs.联合口服低剂量环磷酰胺内分泌治疗可能通过 TLSs 中的 Tregs 改善转移性乳腺癌患者的临床反应。
Sci Rep. 2024 Jun 11;14(1):13432. doi: 10.1038/s41598-024-64042-3.
5
Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters.宫颈癌相关三级淋巴结构(TLSs)的异质性及其与临床病理参数的特定相互关系。
Cureus. 2024 Apr 26;16(4):e59077. doi: 10.7759/cureus.59077. eCollection 2024 Apr.
6
Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer.乳腺癌免疫治疗中三级淋巴结构的研究进展
Front Oncol. 2024 Apr 2;14:1382701. doi: 10.3389/fonc.2024.1382701. eCollection 2024.
7
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications.癌症中的三级淋巴结构:免疫机制及临床意义
MedComm (2020). 2024 Mar 11;5(3):e489. doi: 10.1002/mco2.489. eCollection 2024 Mar.
8
Reassessing Breast Cancer-Associated Fibroblasts (CAFs) Interactions with Other Stromal Components and Clinico-Pathologic Parameters by Using Immunohistochemistry and Digital Image Analysis (DIA).通过免疫组织化学和数字图像分析(DIA)重新评估乳腺癌相关成纤维细胞(CAFs)与其他基质成分及临床病理参数的相互作用。
Cancers (Basel). 2023 Jul 27;15(15):3823. doi: 10.3390/cancers15153823.
癌症微环境决定喉癌肿瘤浸润淋巴细胞密度和三级淋巴结构的形成。
Head Neck Pathol. 2023 Jun;17(2):422-432. doi: 10.1007/s12105-022-01517-7. Epub 2022 Dec 31.
4
Identification of a minimum number of genes to predict triple-negative breast cancer subgroups from gene expression profiles.从基因表达谱中鉴定预测三阴性乳腺癌亚群所需的最小基因数。
Hum Genomics. 2022 Dec 20;16(1):70. doi: 10.1186/s40246-022-00436-6.
5
High endothelial venules proportion in tertiary lymphoid structure is a prognostic marker and correlated with anti-tumor immune microenvironment in colorectal cancer.三级淋巴结构中的高内皮静脉比例是结直肠癌的预后标志物,并与抗肿瘤免疫微环境相关。
Ann Med. 2023 Dec;55(1):114-126. doi: 10.1080/07853890.2022.2153911.
6
The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer.单核细胞,乳腺癌肿瘤微环境(TME)中的指挥家。
Cancers (Basel). 2022 Nov 7;14(21):5460. doi: 10.3390/cancers14215460.
7
Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?为什么肿瘤浸润淋巴细胞在治疗实体瘤方面的疗效存在差异?
Front Immunol. 2022 Oct 21;13:973881. doi: 10.3389/fimmu.2022.973881. eCollection 2022.
8
Tumor vessel co-option: The past & the future.肿瘤血管共选:过去与未来
Front Oncol. 2022 Aug 31;12:965277. doi: 10.3389/fonc.2022.965277. eCollection 2022.
9
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities.三阴性乳腺癌的免疫治疗:对肿瘤免疫微环境和治疗机会的见解
Front Mol Biosci. 2022 Aug 19;9:903065. doi: 10.3389/fmolb.2022.903065. eCollection 2022.
10
Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma.皮肤鳞状细胞癌中三级淋巴结构的特征和临床意义。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2043-2050. doi: 10.1111/jdv.18464. Epub 2022 Aug 4.